Structural Biology in Cancer Research

The main aim of integrating structural biology data into cancer research is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modelling mainly aims at drug designing. Consequently, a number of Structural Biologists are conducting cancer research, to speed-up the process of understanding the mechanism of biomolecules in order to improve the newer cancer therapies.
Major part of research is being carried out in the area of cancer. The main aim is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modelling mainly aims at drug designing. Subsequently, numerous team leaders in Structural biology carry out cancer research to accelerate the exploitation of molecular understanding of biomolecules in the advancement of novel cancer therapies.

  • Cancer Systems Biology
  • Tumorigenesis
  • Cancer Heterogeneity
  • Epidemiology
  • Statistical and Mechanistic Modelling of Signalling Networks

Related Conference of Structural Biology in Cancer Research

June 13-14, 2024

30th Asia Pacific Biotechnology Congress

Dubai, UAE
July 11-12, 2024

6th International Conference on Biochemistry

Paris, France
September 25-26, 2024

20th World Congress on Structural Biology

Paris, France
October 03-04, 2024

15th International Conference on Biofuels and Bioenergy

Singapore City, Singapore
December 12-13, 2024

15th World Congress on Cell & Tissue Science

Rome, Italy

Structural Biology in Cancer Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in